Theme C Proffered Paper Session 7: Rapid fire, testing and PrEP
Tracks
.
| Wednesday, September 26, 2018 |
| 3:30 PM - 4:30 PM |
| Ionic (Ground Floor) |
Speaker
Mr Mark Fisher
Executive Director
Body Positive Inc
Drop In Rapid Testing At Community Agency
3:30 PM - 3:35 PMBiography
Mark has been involved with the HIV sector since 1992 working the National HIV reference Laboratory. Then engaged with Ontario Public Health Laboratory with a focus on testing and epidemiology. he then moved tot he Ontario HIV treatment Network before moving to NEw Zealand to join Body Positve
Rodrigo Olin
Senior Project Officer
New Zealand AIDS Foundation
Quick Prick at the Park – Taking Testing to the Beats
3:35 PM - 3:40 PMBiography
Rodrigo is the senior Project Officer at the New Zealand AIDS Foundation within the community engagement team. He has worked in the HIV/AIDS field for over 10 years as an activist and community peer educator in New Zealand and Mexico. Rodrigo has been living with HIV since 2003.
Mr Jason Asselin
Surveillance & Evaluation Manager
Burnet Institute
Segmented Linear Regression To Assess HIV Testing Among Prepx And Non-Prepx Participants During Rapid Prep Scale Up In Melbourne, Australia.
3:40 PM - 3:45 PMBiography
Jason Asselin is the coordinator Australian Collaboration for Coordinated Enhanced Surveillance (ACCESS) and has a focus on HIV epidemiology at the Burnet Institute. He has worked in both HIV and STI surveillance and health promotion, both here and in Canada since 2005.
Dr Benjamin Bavinton
Senior Research Fellow
Kirby Institute
Coverage of sex events with HIV pre-exposure prophylaxis (PrEP) during EPIC-NSW study follow-up
3:45 PM - 3:50 PMBiography
Benjamin has worked in the field of HIV prevention, policy and research for nearly 15 years both in Australia and internationally. He is currently a Postdoctoral Research Fellow at the Kirby Institute.
Dr Stefanie Vaccher
Statistician/Epidemiologist
Kirby Institute
Baseline Preferences For Daily And Non-Daily Prep Dosing In EPIC-NSW
3:50 PM - 3:55 PMBiography
Stefanie is a statistician/epidiemiologist working on the EPIC-NSW study, one of the largest studies of daily oral PrEP in the world. She is also completing her PhD on adherence to PrEP at the Kirby Institute.
Prof Mark Stoove
Head, Public Health Discipline, Co-Head of the HIV Elimination Program
Burnet Institute
Dr Mo Hammoud
Research Fellow & Research Group Leader
Kirby Institute, UNSW Sydney
Increase In Uptake And Incidence Of HIV Pre-Exposure Prophylaxis (PrEP) Among Gay And Bisexual Men In Australia.
4:00 PM - 4:05 PMBiography
Mo is a Senior Research Manager at the Kirby Institute. He was responsible for the design and implementation of an automated cohort management systems which was adapted for use in two Australian PrEP trials, EPIC-NSW and PrEPIT, and the national drug study ‘Flux’ which is currently expanding to New Zealand.
Dr Phill Read
Director, Sexual Health and Blood Borne Viruses - SESLHD/ Director, Kirketon Road Centre
South Eastern Sydney LHD
Perceptions of HIV Pre-Exposure Prophylaxis Among People Who Inject Drugs
4:05 PM - 4:10 PMBiography
Dr Phillip Read is the Director of the Kirketon Road Centre. He has been involved in sexual health medicine since the early 2000s and is a prescriber for HIV and HCV treatment. He participated as principal investigator on several studies in sexual health, HIV, viral hepatitis, and drug-related health care.
Q&A
Q&A
4:10 PM - 4:30 PMBiography
Chair
Nicholas Medland
Researcher
The Kirby Institute
Tim Wark
